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Background: Irritable Bowel Syndrome (IBS) is a functional bowel disorder that affects 
approximately 10-20% of New Zealanders. Currently, there is no curative treatment for IBS 
and IBS management focuses on symptomatic relief. The low FODMAP diet taught in a one-
to-one setting by a dietitian, is a validated dietary therapy in managing IBS symptoms. Yet, 
the number of patients requring low FODMAP education is exceeding dietetic capacity. 
Group education and alternative delivery models have to be investigated.  
Objective: This was a feasibility study for an non-randomised, interventional pilot study 
investigating the impact of a dietitian-led low FODMAP group education programme for 
adults with IBS living in Christchurch, New Zealand. This study aimed to examine the effects 
of this programme on gastrointestinal symptoms in a sample of New Zealand adults with a 
clinical diagnosis of IBS. It also aimed to explore participants’ perspectives and acceptability 
of the low FODMAP diet and the group education programme itself.  
Design: The group education programme was advertised to general practices in the 
surrounding areas of the proposed session venues. Due to low referral rates from general 
practices, the sessions were also advertised on Community HealthPathways and Health Info 
Canterbury, promoted by the Canterbury Initiative leadership team on their practice visits and 
in the Pegasus Health email newsletter.  The study aimed to recruit twenty-five adults with 
IBS. Information on baseline characteristics was provided and participants were booked to 
attend the first education session. The first session focused on how to implement and follow a 
low FODMAP diet. Participants followed the low FODMAP diet for six weeks. Participants 
were then called to determine if they found their IBS symptoms to be improved by ≥ 50% 
whilst being on the low FODMAP diet. Those that improved by ≥ 50% were invited to attend 
the second education session which focused on the reintroduction and rechallenging of 
FODMAPs. Participants completed the Structured Assessment Gastrointestinal Symptoms 
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Scale (SAGIS) and Hospital Anxiety Depression Scale (HADS) questionnaires at baseline 
and after the intervention. They also completed a semi-structured interview that elicited 
participant’s perspectives around barriers and facilitators in adhering to the low FODMAP 
diet as well as their perceived acceptability of the group education programme.  
Outcomes: In total, twenty-five participants were recruited. Twenty-two participants were 
booked into the first education session and three participants dropped out due to work and day 
commitments. The majority of the mean SAGIS scores significantly decreased between 
baseline (1.844) and follow-up (0.607) (p<0.05). There was a non-significant improvement in 
the HADS anxiety and depression scores from baseline to follow-up. Thirteen out of 
seventeen (76.5%) participants reported symptomatic improvement while two participants 
(11.8%) did not improve and two others (11.8%) did not implement the diet at all. Overall, 
participants were positive and grateful for the changes the low FODMAP diet made to their 
symptoms. Common barriers of the low FODMAP diet included eating out, social situations 
and restricting garlic and onion containing foods from the diet. Factors that helped 
participants adhere to the diet included having supportive partner/family, using the web apps 
and websites and meal planning.  
Conclusion: A dietitian-led low FODMAP diet group education programme in a sample of 
twenty-two Christchurch adults diagnosed with IBS predominant diarrhoea (IBS-D) or IBS 




The current study was a feasibility study to assess the effectiveness and acceptability of a 
dietitian-led low FODMAP group education programme for patients with irritable bowel 
syndrome (IBS). The initial concept for this feasibility study was developed by Sally Watson 
(Canterbury Initiative). Professor Richard Gearry, Dr Paula Skidmore and Leigh O’Brien 
were responsible for developing the study, obtaining ethical approval and overseeing the 
project.   
The candidate was responsible for the following tasks:  
 Drafting initial ethics  
 Making amendments to the initial ethical approval document (University of Otago 
Human Ethics Committee, Category A) 
 Making amendments to participant information sheet and consent forms  
 Explaining the study protocol and intervention to participants  
 Confirming and booking participants for the sessions  
 Sending questionnaire and consent forms to participants  
 Collecting questionnaires and consent forms  
 Compiling written resources for participants  
 Development of research protocols to be used throughout the study  
 Contributing and reviewing the study data collection process  
 Development of semi-structured interviews 
 Conducting and recording all semi structured interviews  
 Transcribing semi-structured interview verbal data  
 Thematic analysis of transcribed interview  
 Determining if participants had sufficient symptomatic improvement on the low 
FODMAP diet and hence invited to the follow up sessions 
 Write up of this thesis  
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 Assembling quantitative questionnaire data for analysis in SPSS, with advice from 
Professor Chris Frampton (Biostatistician, Department of Psychological Medicine, 
University of Otago) and Dr Simone Bayer (PhD)  
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Irritable Bowel Syndrome (IBS) is a common functional bowel disorder that affects 
approximately 11% of the population of the developed world (1). It is predominant in females 
(64% of those with IBS) and the peak onset is between 25-54 years of age (2). In New 
Zealand, it is estimated that IBS affects approximately 10-20% of individuals (3). No formal 
research on trends has been conducted in New Zealand but with the increasing referral rates 
for IBS management, it can be assumed that the prevalence of IBS in New Zealand is 
increasing.  
 
IBS is often a debilitating condition and characterised by symptoms of abdominal pain, 
bloating and altered bowel habits (4). IBS can also negatively affect one’s quality of life. 
Psychological distress and psychiatric disorders such as anxiety and depression are often 
comorbidities of IBS (5, 6). Somatisation is found to be a key aspect of IBS and many argue 
that psychological distress exacerbate severity of IBS symptoms (7, 8). IBS has also proven to 
be a financially costly condition, with management involving an array of health professionals, 
medications and dietary management in addition to indirect costs (9).  
There is currently no curative treatment for IBS and hence the management of IBS is to 
provide symptomatic relief. Most individuals perceive food as triggers to their IBS symptoms 
and dietary management is considered to be first-line IBS management (10, 11). General first 
line dietary advice includes fibre modification, adequate fluids and general health eating 
guidelines (12-14). Such advice can be delivered by a health professional unrelated to 




In the past 13 years, the low FODMAP diet has become a front-line therapy for IBS 
management. A diet low in fermentable carbohydrates collectively termed fermentable 
oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) has been 
extensively studied and shown to reduce symptoms in approximately 68-70% of patients (5, 
6). Yet, the low FODMAP diet is complex and restrictive, which can result in nutritional 
concerns, nutrient deficiencies and disordered eating patterns. A guided implementation of the 
low FODMAP diet is required for safety and efficacy. Registered dietitians have extensive 
knowledge and skills regarding nutrition and dietary counselling. Dietitians have been 
effective in delivering low FODMAP education in an increasing number of randomised 
controlled trials (RCTs) and non RCTs (5, 15-22). Traditionally, patients attend a one-to-one 
consultation with a dietitian for two to three sessions. However, the number of patients 
requiring low FODMAP education is exceeding dietetic capacity and hence other more 
effective delivery methods have to be considered.  
A landmark study from King’s College (London, UK) found that a dietitian-led low 
FODMAP group education programme is as clinically effective as the traditional one-to-one 
pathway (20). Their findings suggested that group education has potential benefits in patient 
acceptability and interactive learning as well being more cost effective (20). No formal 
research regarding low FODMAP group education has previously been conducted in a New 
Zealand population and setting. Consequently, the aim of this thesis is to assess the feasibility 





2.1     Irritable Bowel Syndrome (IBS) 
2.1.1   What is Irritable Bowel Syndrome 
Irritable Bowel Syndrome (IBS)  is a functional gastrointestinal disorder that is characterised 
by symptoms of abdominal pain, bloating and altered bowel habits such as constipation, 
diarrhea or both (4). 
2.1.2   IBS Prevalence and Trends 
IBS affects 10-20% of the Western world's population (1). The prevalence of IBS changes 
according to geographic location (23). The varying prevalence could be due to different 
diagnostic criteria, environmental and genetic influences and other factors, such as health care 
utilisation, sanitation and diet (23, 24). In New Zealand,  IBS is estimated to affect 21% of 
New Zealanders (3). The prevalence of IBS is greater in women than in men and lower in 
individuals aged over 50 years (1, 23).     
2.1.3  IBS Diagnosis 
There are no structural abnormalities of the gastrointestinal tract in people with IBS (25). 
Hence, clinicians use an exclusion and symptomatic approach to make a clinical diagnosis for 
IBS (26, 27). The newly revised ROME IV criteria are currently used and are considered the 
gold standard for IBS diagnosis (Table 1) (28). Four bowel patterns (defined using the 
ROME IV criteria) may occur in IBS; IBS-D (diarrhoea predominant), IBS-C (constipation 
predominant), IBS- M (mixed constipation and diarrhea) and IBS-U (unspecified) (29). 
Questionnaires such as the validated Structured Assessment Gastrointestinal Symptoms Scale 
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(SAGIS) have also been developed to assess the severeity and frequency of gastrointestinal 
symptoms experienced in IBS patients (30).  
Table 1. Rome IV Criteria for Diagnosing IBS (28). 
Recurrent abdominal pain at least 1 day/week in the last 3 months, with at least two of the following 
criteria:  
• Related to defecation 
• Associated with a change in frequency of stool  
• Associated with a change in form (appearance) of stool  
The criteria should be met for the last 3 months and the symptoms begin at least 6 months before 
diagnosis. 
 
2.1.4   IBS Pathogenesis 
The exact cause of IBS is unknown, however there is increasing research concerning its 
possible pathogenesis including visceral afferent hypersensitivity, changes in the brain-gut 
axis and genetic predisposition (31-33). Hence, the cause of IBS is most likely to be 
multifactorial. The management of IBS is aimed less at the cause of IBS symptoms but to 
relieve the patient of their symptoms. In particular, the effects of diet on IBS are well 
described. It has been hypothesised that the stimulation of nutrient specific receptors in the 
gut leads to the activation of neurohumoral pathways that influence sensitivity, motility and 
intestinal barrier function (34). Components of an individual’s diet could be directly related to 
the IBS symptoms experienced. Thus, diet should be considered as a cornerstone of IBS 
treatment.  
2.1.5   IBS Consequences 
IBS can negatively affect one’s quality of life and when compared to other chronic illnesses 
(e.g. inflammatory bowel disease, diabetes and end stage renal disease) those with IBS 
reported a lower quality of life (35, 36).  Furthermore, psychiatric disorders such as anxiety 
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and depression are often co-morbidities of IBS and other functional gut disorders (37). In 
comparison to inflammatory bowel disease (IBD) patients, IBS patients are more likely to 
have more severe comorbidity depressive and anxiety symptoms (38). Conversely, 
somatisation is a key aspect of IBS and research shows that psychiatric disorders and 
psychological distress are likely to exacerbate gastrointestinal symptoms and in some cases 
provide the onset of IBS symptoms (7, 8). Questionnaires like the Hospital Anxiety 
Depression Scale (HADS) have been validated and widely used in clinical settings, 
community settings as well as primary care practice (39).   
IBS is also a financially costly condition for the economy. Productivity costs are significant in 
conditions like IBS that have a higher burden of morbidity compared to mortality (40). 
Individuals with IBS are twice as likely to take time off work compared to their colleagues 
and 72% report that IBS affects their productivity at work (41, 42).  
2.1.6   Effect of IBS on the health budget 
Approximately one third of IBS sufferers will seek medical advice, nevertheless IBS 
generates a substantial cost to the health care system (2, 43-45). IBS patients generate a 
substantial workload for primary and secondary health care providers, which is comparatively 
greater than patients with diabetes, hypertension and asthma (9). The cost of IBS can be 
broken down into general practice consultations, gastroenterologist consultations, diagnostic 
tests and drug prescriptions (9). Variations in overall healthcare costs for IBS management are 
considerable worldwide. In the United Kingdom, the estimated annual cost per patient is 
between £90 and £316 and in the United States is between $742 and $7,547 (41,46,47,48). In 
New Zealand, there is little research into the cost of IBS, however, it is likely to be expensive 
and a significant burden on the health care system. Furthermore, New Zealand’s ageing 
population is predicted to substantially increase health care costs in the future (49). Some 
argue that the incidence of IBS increases with age, which would further substantiate the 
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financial burden (50, 51). However, a meta-analysis study conducted by Lovell et al 
concluded that IBS prevalence decreases with age (1). Regardless, the high prevalence of IBS 
and an ageing population puts great financial burden on society (49).  
2.2   Management of IBS 
Currently, there is no curative treatment for IBS and the aims of IBS management are to 
relieve patients of their symptoms (Figure 1). Management should be tailored and 
individualised to the patient as not all patients will have the same symptoms nor will they 
respond to treatment in the same way (52). Traditional pharmaceutical approaches using 
antispasmodics, anticholinergics, bulking agents and antidiarrheals do not relieve patients of 
all symptoms when used alone (53, 54). Instead, when used in combination with non-
pharmaceutical methods such as dietary manipulation, exercise and behavioural therapy 
patients report greater overall symptomatic relief (55).  Section 2.2.1 explores evidence for 
some of the dietary manipulations developed to relieve the global symptoms of IBS. 
2.2.1   Role of Diet in IBS Management 
Most patients believe that food plays a role in their IBS symptoms (70-80%) with many 
consequently excluding or avoiding certain foods to decrease the likelihood of symptom 
development (10, 11). Common foods that patients reported to aggravate their symptoms 
include milk and milk products, wheat, caffeine, cabbage, onions, peas, beans, hot spices, 
fried foods and smoked products (56, 57).  
Early studies looking at strict dietary exclusions in IBS patients followed by reintroduction of 
common trigger foods (e.g. milk, wheat) suggested that individual foods exacerbate 
symptoms (57, 58). In a study by Jones et al, 25 participants diagnosed with IBS-D were 
asked to limit their food intake to a single meat, a single fruit and distilled or spring water for 
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a week (59). Four participants refused to implement the diet and only 14 participants (56%) 
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underwent a double blinded food challenge. A liquidised preparation of test foods (foods 
believed to provoke symptoms) vs control foods were administered via a nasogastric tube and 
food intolerance was confirmed.  A subsequent study that followed the same dietary 
restrictions and protocols but included other subtypes of IBS, found that only six out of 40 
(15%) of participants with IBS had seen symptomatic improvement, with the majority being 
subtype IBS-D (60). The variability in the responses of exclusion diets is likely due to the 
differences in study duration, types of foods excluded and differing recruitment criteria. There 
is also a lack of randomised controlled trials to support exclusion diets. Due to the nature of 
dietary interventions, designing randomised controlled trials is difficult in regards to blinding 
participants. Furthermore, the mechanism and theories as to why some participants experience 
improvements on exclusion diets are not well explained.  
In more recent times, dietary supplementation through the use of probiotics have been shown 
to help with some IBS symptoms but not all (61, 62). One randomised controlled trial found 
that probiotic treatment significantly improved abdominal pain in 400 patients (62). However 
this study only included patients with IBS-D meaning that its findings cannot be generalised 
in all IBS subtypes. Probiotic supplementation could be used to manage some IBS symptoms 
but other approaches are required for an overall IBS symptomatic improvement.  
There is variable evidence for the efficacy of fibre supplementation in IBS patients. The 
theory is that dietary fibre is slowly, incompletely or essentially not fermented in the gut and 
therefore, able to provide bulk and help regulate bowel function. Recently, Singh et al 
conducted a systematic review of 17 randomised controlled trials and concluded that there 
were no significant benefits of dietary fibre in the treatment of IBS patients (63). Only one 
study concluded that wheat bran was able to reduce the severity and/or frequency of 
symptoms significantly (64). Conversely, another study found that bran supplementation 
worsened patients’ IBS symptoms (65). In conclusion, there is limited evidence for the 
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supplementation of dietary fibre. As part of a healthy diet, patients with IBS should aim for 
the same amount of dietary fibre as normal individuals.  
Wheat or gluten avoidance in the absence of coeliac disease is common but there is mixed 
evidence to support a gluten free diet in those with IBS. A double blinded, randomised 
controlled study of 34 patients with IBS, found that bloating, pain and stool consistency 
worsened in the gluten inclusive diets when compared to those on a gluten-free diet (66). 
Subsequently in the same study, 14% of subjects were classified as having non-coeliac gluten 
sensitivity and the rest had IBS (67). A double blinded, cross over trial of the same group 
found that there were no specific effects of dose responses to gluten while symptoms were 
improved while being on the low FODMAP diet (67). This suggests fructans and galacto-
oligosaccharides found in wheat may trigger IBS symptoms, rather than gluten. There is 
emerging research highlighting concerns about a gluten free diet in the absence of a gluten-
mediated immunological disease. Potential concerns of following a gluten-free diet include 
deficiencies in micronutrients and fibre, hyperlipidaemia and hyperglycaemia (68). As the 
current evidence stands, a gluten-free diet should only be recommended for patients with 
clinically diagnosed coeliac disease or dermatitis herpetiformis.  
The FODMAP concept was first published by Gibson and Shepherd as a hypothesis for 
Crohn’s Disease in 2005(69). They suggested that an excessive delivery of highly fermentable 
but poorly absorbed short chain carbohydrates to the small and large bowel affected intestinal 
permeability, a risk factor in Crohn’s disease (69). Though the hypothesis was intended for 
Crohn’s Disease, researchers theorised that these highly fermentable but poorly absorbed 
short chain carbohydrates also played a part in inducing symptoms experienced in patients 
with IBS. In 2006, a retrospective study found that a diet restricted in fructose and fructans 
gave relief to 76% of participants with IBS (70). In a subsequent blinded rechallenge study, 
the participants that had responded positively were randomly challenged by graded doses 
introduction of fructose, fructans or both, or glucose taken as drinks.  Overall symptoms and 
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severity were markedly less for groups that received glucose drinks (control) as opposed to 
the groups that received fructans or fructose drinks alone or combined (70). These studies 
were the first to demonstrate that dietary restriction of poorly absorbed carbohydrates led to 
symptomatic improvements. At the time there was no collective term for these carbohydrates 
and eventually in 2004, the Monash Group agreed on the term; Fermentable Oligosaccharides, 
Disaccharides and Monosaccharides and Polyols (“FODMAP”) (71). Today, the low 
FODMAP diet is one of the most studied dietary therapies for the treatment of IBS symptoms 
(72). As discussed, there are many dietary factors that can contribute to IBS symptoms, 
however, FODMAPs are the most researched and have the most consistent results. The 
following sections will explore the evidence and application of the low FODMAP diet.  
2.2.2   The low FODMAP diet 
FODMAPs is a term given to a group of carbohydrates that are poorly absorbed in small and 
large intestine (71). The low FODMAP diet focuses on reducing the consumption of foods 
that contain high amounts of FODMAPs (69, 70, 72). Table 2 lists examples of common 
foods that are found to be high in FODMAPS and examples of low FODMAP alternatives.  
Clinical implementation of the low FODMAP diet occurs in a two phases. Firstly, patients are 
given in-depth dietary advice on FODMAP restriction followed by dietary exclusion of 
FODMAPs for two to six weeks (72). Where symptomatic improvement has been achieved, 
patients are taught to reintroduce these carbohydrates individually into the diet while 
symptoms are closely monitored (72). The overall aim of the low FODMAP diet is to identify 
the specific carbohydrates that trigger IBS symptoms whilst achieving a diverse and 

















High FODMAPs foods Low FODMAP food alternatives 
Fructans and 
Galactans  
Wheat, barley, rye, garlic, onions, dried fruit, 
nectarines, watermelon, split beans, red 
kidney beans, baked beans, pistachios and 
cashews. 
Bok choy, bell peppers, carrots, broccoli, 
cabbage, cucumber, eggplant, green 
beans, kale, lettuce, potatoes, rice, 
quinoa, corn chips, oats, polenta, corn, 
tortilla, pecan, chia, peanuts, walnuts, 
flax, pumpkin seeds, sesame seeds and 
sunflower seeds. 
Lactose Milk (fresh, evaporated, condensed, long life 
and milk powder), custard, ice cream, 
yoghurt, dairy food, ricotta, cottage cheese, 
sour cream and cream cheese.  
Colby, cheddar, brie, edam, camembert, 
feta, mozzarella, gouda, parmesan, 
lactose free cow’s milk, almond milk, rice 
milk, lactose-free yoghurt and some soy 
milks.  
Fructose  Apples, figs, boysenberries, pears, 
watermelons, asparagus, snap peas, honey, 
rum, cherries and fruit juice.  
Blueberries, grapes, mandarins, kiwifruit, 
lemons, limes, pineapples, raspberries, 
strawberries and papaya.  
Polyols  Apples, apricots, blackberries, nectarines, 
peaches, pears, cauliflower, mushrooms, 
snow peas, sugar alcohol additives such as 
mannitol, sorbitol and xylitol. 
Blueberries, mandarins, grapes, 
honeydew, melon, lemon, limes, oranges, 
pineapples, strawberries, table sugar, 
glucose, maple syrup, sucralose and 
stevia. 
Notes: Data adapted from Monash University: Low FODMAP Diet Application. Available at 
https://www.monash.edu/medicine/ccs/gastroenterology/fodmap. Android version accessed July 23 2018.  
Abbreviations: FODMAP, fermentable oligosaccharide, disaccharide, monosaccharide, and polyols, FOS, fructo-
oligosaccharides, GOS, galacto-oligosaccharides.  
17 
 
2.2.3   How does a low FODMAP diet work in IBS  
FODMAPs are responsible for two main mechanisms that contribute to the common 
symptoms experienced by patients diagnosed with IBS. FODMAPs are short chained 
carbohydrates that are poorly absorbed in the gastrointestinal system. First, the poor digestion 
of FODMAPs leads to excess water moving osmotically into the small intestine. This may 
result in luminal distention and abdominal pain as well as the increase of water being 
delivered to the proximal colon. A variety of studies have demonstrated the effect of 
FODMAPs in the small intestine. In a study that included ileostomates, ileal effluent was 
increased by up to 22% and output was increased by 95ml after a meal containing high 
FODMAP foods (73). This mechanism is supported by a more recent study that used 
magnetic resonance imaging (MRI) (74). This randomised controlled trial used MRI 
technology to visualise intestinal responses to intake of lactulose in IBS patients and healthy 
controls and found that small bowel water content was significantly higher in IBS patients 
compared to controls (74).   
Secondly, as FODMAPs are not absorbed by the small intestine they move to the large 
intestine for further digestion. Once here, FODMAPs are fermented by the colonic microbiota 
and during this process excess gas is produced. Due to gas production and water retention, 
this leads to luminal distension and expansion of the intestines. A study that used hydrogen 
breath testing found that FODMAPs prolonged hydrogen and methane gas production in IBS 
patients compared to healthy controls, inducing the gastrointestinal symptoms experienced by 
IBS patients particularly bloating and abdominal pain (75). Thus this supports the hypothesis 
that the rapid fermentation of FODMAPs in the colon results in luminal distension, gas 
production and bloating of the large bowel. 
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2.2.4   Clinical studies of low FODMAP diet and IBS 
In the past 10 years, a range of studies have been performed that support the efficacy of a low 
FODMAP diet in the management of IBS symptoms. Approximately 50-76% of patients with 
IBS report symptom improvement after implementing the low FODMAP diet as shown in 
Table 3 (5, 15-19, 22). Hence, it has been adopted for use in clinical practice. Although there 
is research supporting the efficacy of a low FODMAP diet, not all who follow the diet will 
experience the same degree of relief or improvement which aligns with the pathophysiology 
of IBS (76). 
Many studies of the low FODMAP diet are limited by retrospective study design, or lacking a 
control or comparator group making these studies vulnerable to confounding and bias. 
Furthermore, randomised controlled trials that include dietary interventions mean that 
blinding participants to dietary interventions is particularly difficult. In addition, there are 
psychological factors involved in symptom genesis of IBS and hence the placebo effect can 
lead to bias (12). In a meta-analysis conducted by Patel et al (77), the placebo response 
averaged to be 40% across 45 IBS RCTs. Currently, there are few dietary assessment tools to 
analyse adherence when following the low FODMAP diet. Nevertheless, some good quality 
RCTs have been conducted and are reviewed in Table 3. These studies were conducted in 
Australia, New Zealand, USA, Sweden, Canada, Denmark and the United Kingdom. 
The majority of the studies were small in size, ranging from 30 -123 participants (58-64). The 
studies were conducted in Western countries, in predominantly Western populations (58-64). 
The mean age of participants was 42 years and a mean proportion of 70% female participants 
across the studies. IBS diagnosis was made using the ROME III criteria, with Staudacher et al 
being the only exception, using the National Institute for Health Care and Excellence (NICE) 
guidelines (78).  Studies that used ROME IV criteria were not available at the time of this 
thesis. Randomised, double blinded, placebo controlled studies are considered to be the gold 
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standard of evidenced based research. However due to the nature of dietary interventions, 
only four out of seven of the studies were blinded and in most cases only the participants were 
blinded. The majority of the studies were two armed RCTs, with one arm being the low 
FODMAP diet and the other being the control diet. The duration of the study period varied 
between studies from three weeks to six months and in nearly all the studies that provided 
dietary education, this was delivered by a dietitian in one to one setting. Almost all the studies 
measured gastrointestinal symptoms in some form and a few looked at IBS related quality of 
life also. Only three of the studies looked at adherence to the allocated diets. Adherence was 
measured using food diaries, 24 hour recall and hydrogen breath testing.  
Over the past 10 years, the efficacy of a low FODMAP diet to manage IBS symptoms 
remains consistent. Most studies demonstrate that the gastrointestinal symptoms are reduced 
and alleviated after following a low FODMAP diet. Furthermore, psychological measures 
and, hence, quality of life has also shown to improve after following a low FODMAP diet. In 
a prospective, single blind study of 84 patients, anxiety scores measured by the HADS 
improved significantly following a low FODMAP diet and additionally IBS-QoL scores 
improved significantly also. Another study of 209 IBS patients found that high FODMAP 
containing foods worsened IBS symptoms and severity was intensified if the patient had 
anxiety and/or depression (56). Overall, there is high quality literature that supports the use of 
the low FODMAP diet in the management of IBS patients in terms of symptomatic 
improvement as well as psychological and health-related quality of life outcomes (Table 3). 
2.3   Who should deliver the low FODMAP diet 
Clinical studies support the role of the low FODMAP diet in the management of IBS, 
however there is currently no statement on who should be delivering the low FODMAP diet 
(5, 15-17, 19). Table 4 provides an overview for the evidence as to who has delivered low 
FODMAP diet education in patients with IBS in clinical studies.  
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2.3.1   Dietitians 
Registered dietitians have extensive knowledge about diet and nutrition. They are governed 
by ethical code to practice using evidence based guidelines only. Dietitians have also been 
directly involved in research to investigate IBS and the mechanisms behind low FODMAPs 
among other health-nutrition related issues (79).  There have been an increasing number of 
RCTs and non-RCTs that support the use of the low FODMAP diet in IBS management, most 
of these studies utilising dietitians to deliver advice and education about the diet (5, 15-21, 
80).  Reflective of the standard treatment pathway, most studies involved two intensive one-
to-one consultations with a registered dietitian. The initial consultation provided education on 
the low FODMAP diet and tailored dietary advice was given. In some cases, patients were 
advised to complete a food diary prior and adjustments were made with the patient 
accordingly.  A dietitian-led approach is the most researched and established in low 
FODMAP education. Furthermore, it is the only approach that aligns with current evidence-
based practice and guidelines.   
2.3.2   Medical staff  
There have been studies of a nurse-led approach to improve IBS symptoms; however these 
studies predominantly looked at IBS first line dietary management. The studies had a high 
dropout rate (20-40%) and one of the studies failed to find any significant differences in 
gastrointestinal symptoms between the intervention and control groups (81). Yet, another 
nurse-led dietary education programme with an emphasis on FODMAPs found a significant 
increase in patient reported quality of life scores after attending the programme(82). While no 
published studies had been completed, doctors have reported to provide patients with basic 
information. One survey reported 79% of doctors gave advice of IBS and dietary management 
to their patients on the low FODMAP diet (for example, a one page leaflet or links for 
webpages online)(83). However this deviates from evidenced based practice and due to the 
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challenges and restrictive nature of the low FODMAP diet, it is unlikely that patients benefit 
from this sort of education delivery. It seems intuitive that a person providing low FODMAP 
education needs to be trained in that area. Dietitians are experts in diet and nutrition and hence 
would be the favourable health professional to deliver low FODMAP advice.  
Other sources of information 
With the increasing awareness of the low FODMAP diet, there are an increasing number of 
websites, blogs and social media posts proclaiming to assist individuals with the low 
FODMAP diet. The individuals behind these media platforms are usually bloggers, fitness 
experts or ‘internet gurus’ with no qualifications or evidence to support their messages.    
However, there are emerging resources online and thus research in this area to investigate the 
efficacy and effectiveness of these resources. Schneider et al found that the use of a self-help 
guidebook and had a positive impact on IBS related quality of life (85). However, it failed to 
assess any differences in gastrointestinal symptoms, did not assess dietary adequacy and had a 
high dropout rate of 25%. 
An unguided implementation of the low FODMAP diet creates uncertainty in regards to the 
diet being correctly followed. This may also prove to be more problematic in specific 
populations such as in vegetarians, vegans, pregnant women or individuals with other diseases 
and medical conditions. Due to the restrictive nature of the low FODMAP diet, this also has 
the potential to create overly restrictive eating patterns. These concerns further support the 
need for dietetic input in the delivery of the low FODMAP diet.  
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Table 3. Randomised controlled trials of low FODMAP diet in adults with IBS. 
 






Dietary intervention  Duration  Outcome 
measures  
Key results  
Harvie et 






n = 50 
LFD n = 23  
ND n = 27 
 LFD group received LFD 
education at baseline and 
then reintroduction of 
foods at 3 months. 
 Control group received 
dietary education 3 
months after study 
commenced. 
6 months  IBS-SSS  
IBS –QoL 
FODMAP FFQ  
Stool sample  
 Significantly lower IBS-SSS 
score and higher IBS-QoL 
scores in LFD at 3 months 
compared to baseline. 
Lower IBS-SSS score 
sustained at 6 months.   
 Similar affects seen in 
control group however 
not to as great effect as 
LFD group. 
 27 participants lost to 
















n = 123   
LFD n= 42 
LGG n=41 
ND n=40 
 LFD group attended a one-
to-one, one-hour session 
by nutritionists or 
dietitians. List of high 
FODMAP foods were 
provided at the session.  
 LGG group were to 
administer LGG capsules 
twice daily. 
 ND group were advised to 
make no changes to their 
normal diets. 
 
6 weeks  IBS-QoL  
IBS SSS  
Both 
completed on 




 IBS-QoL not significantly 
altered across the three 
groups. 
 IBS-SSS scores were 
significantly reduced in all 
groups. 
 LFD -75 vs ND -32 p<0.01 















HFD n= 19 
 All participants met with 
dietitian for a 30-60              
minute consult to review 
components of their diets 
and make the suitable 
changes.  
 Dietary booklet given that 
included sample menus 
for either high or low 
FODMAP depending on 
participant’s allocation.  
 







 IBS-SSS score significantly 
reduced in LFD group 
compared to HFD 
(p<0.001). 
 37 participants completed 










LFD n= 38 
ND n= 37 
 All participants met with 
dietitians individually to 
discuss LFD or ND dietary 
advice according to their 
group allocation.  
 Traditional IBS dietary 





Four day food 
diary  
 IBS SSS scores reduced in 
both groups after 4 weeks 
(p<0.0001). 
 No significant difference 
between the two groups  
 65 participants completed 











cross over study 
design (single 
blind). 





 Randomly assigned to LFD 
or ND. All food was 
provided for.  
 Wash over period of 21 








content   
Food diaries 
on habitual 
diet (one week 
prior to diets) 
 Participants with IBS that 
followed LFD had 
significantly lower GI 
symptoms scores than ND. 
 Bloating, pain and gas 
reduced with the LFD in 
IBS subjects.  
 Symptoms minimal and 
unaltered in controls.  
 7 participants did not 
complete the study, 15% 














LFD  n= 43 
ND n=39 
 All participants were seen 
by a dietitian. 
 Two consultations with 
dietitian. 
 LFD group given education 
on low FODMAP diet and 
how to reduce intake of 
FODMAPs. 
 Controls given standard 
dietary guidelines based 





Likert scale  LFD group reported better 
overall GI symptom 
response compared to ND 
group (p<0.001). 
 LFD group reported to 
having significantly less 
flatulence and bloating 
compared to ND group.  
 3 participants failed to 
complete the study, 4% 












LFD n= 45 
mNice n= 39 
 All participants met with 
dietitian to discuss their 
allocated diet  
 LFD was given LFD 
education.  
 mNice group given general 






three day food 
diaries and 24 
hour recall  
IBS-QoL  
HADS 
 Both groups reported 
improvements to GI 
symptoms (p< 0.31). 
 No difference between 
the two groups (p<0.13). 
 Greater reduction of 
abdominal pain in LFD 
group (p< 0.008). 
 8 participants failed to 
complete the study, 9% 
drop out rate. 
Abbreviations: FODMAP, fermentable, oligosaccharide, disaccharide, monosaccharide and polyols; IBS, irritable bowel syndrome; n; number, LFD; low FODMAP diet, ND; 
normal diet, HFD; high FODMAP diet, IBS-SSS; irritable bowel syndrome symptom scoring system, QoL; quality of life, FFQ; food frequency questionnaire, LGG; lactobacillus 




2.4   How should the low FODMAP diet be delivered 
The efficacy of the low FODMAP diet has been largely achieved by the traditional dietitian-
led service delivery models. While the duration, content, number of sessions may differ 
between institutions, intensive low FODMAP education and tailored dietary advice as well as 
close monitoring of gastrointestinal symptoms are imperative. As discussed previously, the 
number of patients requiring low FODMAP education is exceeding dietetic capacity, 
particularly in the public sector. Group education has produced successful results in the 
management of a range of chronic health conditions and is particularly useful when the 
demand outweighs supply. Section 2.4.1 aims to look at group education as an alternative to 




Study  Study Design  Participants  Delivery of low 
FODMAP diet  
Number of 
consultations  
Outcome measures  Key results  
Dietitian 
led 





randomised   
Interventional 
study. 
NICE criteria  
Total n= 364 
Group session  
n= 263  
One to one 
session 
n= 101  
 
 Both groups were 
advised low 
FODMAP 
education by IBS 
dietitians and 
received the same 
FODMAP diet 
resources. 
 Group sessions 
took up to 90 
minutes and 
included up to 12 
participants. 
 One-to-one 
sessions took 60 
minutes. 
 Same approach at 
follow up session. 
One at 
baseline  








 Decrease in both groups after 
following low FODMAP diet 
(p<0.001), however no differences 
between the two groups. 
 54% that attended group session 
versus 60% that attended one to 
one session reported 
improvement (p<0.001). 
 No difference between groups at 
follow up (p<0.27). 
 Acceptability questionnaire: most 
reported that session provided 
enough information without need 
to seek further advice, 85% 
reported that they felt 
comfortable in asking questions 
within the group setting, 36% 
preferred one-to-one sessions, 
with the remainder reporting 
preference for group session (22%) 
and no preference (42%). 
  Cost calculated for one to one 
£139.20 per patient and group 















ROME II  
n= 62 
 Fructose, fructans 
free diet. 
 Dietary education 
was delivered in 
an individual 
consultation 1 
hour with the 
dietitian. 
 The diet was 
reinforced 4-6 
weeks later at the 
participants’ 
request or if the 
dietitian thought 





One session  
or two if 
needed  
 Structured 






 77% of participants adhered to 
diet. 
 74% responded positively to the 
diet. Positive response overall was 
significantly better in the adherent 
vs non adherent (85% vs 36%, 
p<0.01). 




blind study  
ROME III IBS  
n= 75 
 All participants 
met with dietitians 
individually to 
discuss LFD or CG 
dietary advice 
according to their 
group allocation.  
 Traditional IBS 
dietary advice 
given to CG. 
 
One  IBS-SSS  
Four day food diary 
 IBS SSS scores reduced in both 
groups after 4 weeks (p<0.0001). 
 No significant difference between 
the two groups. 
De Roest 






IBS patients  
n= 192 
 Expert dietitian in 
IBS who had been 
involved in the 
implementation of 
low FODMAP diet. 
Two sessions  
six weeks 
apart. 
Likert scale  
 
 13.5% of patients reported never 
following the diet or were not 
adherent to the diet. 
 Significant positive change from 
baseline to follow up. 
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 An initial 1 hour 
appointment with 
dietitian and then 
30 minute follow 
up 6 weeks later. 
 All participants 
completed a 6 day 
food record prior 
to consultation, 
dietitian worked 



















guidance by a 
registered nurse 
with a background 
in IBS. 
management  
 Each session ~45 
minutes long. 
3 sessions  
Each session 
greater than, 







Baseline and >3 months 
after last consult   
 
 Symptoms reduced significantly 
(p<0.001). 
 IBS-QoL score increased 
significantly (p<0.003). 
 40% of participants dropped out of 
study. This high number of drop 
outs is due to several factors; 4% 
due to noncompliance and 
collaboration leading to exclusion, 
9% due to a marked improvement 
in symptoms following the dietary 
guidance leading to lack of 
motivation to continue with the 
study, 7% due to diagnosis of an 
organic disease during the study 
and 4% due to pregnancy and 










Total n= 175  
IBS guided   
n= 70 




 The four 
questionnaires 
sent by mail. 
 Guidance on 
dietary 
management with 
IBS was provided 2 
years prior to the 
study.  
 Two sessions with 
a nurse were 
scheduled for ~1 
hour, regarding 
the disease and 
the role of diet. 
 Diet instructions 
were focused on 
low FODMAPs 
diet, regular meals 
and healthy eating 
habits. 
 
2 sessions  FFQ  
IBS –QoL 
Birmingham IBS 
symptom score  
 Drop out of 20%, mostly due to 
participant’s not replying or 
returning questionnaire. 
 Greater improvement in quality of 
life of guided IBS participants 
compared to unguided (p= 0.015) 
(IBS-QoL). Reduction in quality of 
life was significantly lower in the 
guided than unguided IBS patients.  
 Symptom score was lower in 
guided IBS group than non-guided, 
however this was not significant. 
Self-led    
 











 Self help 
guidebook. 




sent out and 
completed at 3 
months and 6 
months.  
 Self help 
None  FDDQL 
PHQ 
 Quality of life improved at 6 months 
compared to baseline (p< 0.001). 
Depression, anxiety scores were 
lower at 6 months compared to 
baseline (p=0.001). 









also given at 
baseline.  The 
guidebook was 
named ‘Managing 
your Life with 
Irritable Bowel 
Syndrome’ last 




Abbreviations: IBS, irritable bowel syndrome; NICE, National Institute for Healthcare and Excellence;  FODMAP, fermentable, oligosaccharide, disaccharide, monosaccharide 
and polyols; GSRS, gastrointestinal symptom rating scale; BSC, Bristol stool chart, LFD, low FODMAP diet; CG, control group; IBS-SSS, irritable bowel syndrome symptom 
scoring system; QoL, quality of life; FFQ, food frequency questionnaire; FDDQL,  Functional Digestive Disorders Quality of Life; PHQ, Patient Health Questionnaire. 
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2.4.1   Dietitian-led low FODMAP group education  
Whigham et al, were the first to investigate the clinical effectiveness of low FODMAP group 
education sessions in IBS patients. In this newly published observational study, patients were 
offered a telephone consultation by a registered dietitian to assess their suitability for the 
group or individual sessions (20). At the initial appointment (baseline), all patients were 
educated on the low FODMAP by gastroenterology dietitians and both groups received the 
same low FODMAP diet resources. The initial appointment for the group session lasted 90 
minutes and included up to 12 patients while the individual consultations took up to 60 
minutes. At the second appointment (follow up), dietary education was delivered in the same 
approach six weeks later. A total of 263 patients who attended the group sessions were 
compared to 101 patients who attended one-to-one education sessions. There were no 
significant differences between groups for IBS subtypes and symptoms at baseline. At the end 
of the study, the global symptom scores indicated that patients were satisfied with their 
symptoms following dietary advice, in both groups (p<0.001). Overall, there was a significant 
decrease in symptom severity from baseline to follow- up (p<0.001) with no difference in 
symptom response between group and one-to-one education (p=0.271). It was concluded that 
a dietitian-led group education on the low FODMAP diet is clinically effective as one-to-one 
education.  
Whilst, the study found no differences in clinical effectiveness, a cost analysis found that the 
group sessions were substantially more cost effective than the individual sessions. The cost 
calculated was £67.20 ($131.70 NZD) per patient for group education, assuming there were 
12 patients in one group and £139.20 ($272.83 NZD) per patient for one-to-one education. In 
addition, patients allocated to the group sessions also completed an acceptability 
questionnaire at follow up. Patients responded positively, with the majority of patients (81%) 
reporting that group education had provided sufficient information and almost of half of 
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patients (49%) reported the diet being easy to follow. Following group education, 36% 
preferred to have one-to-one education sessions while the remaining 64% preferred group 
education or expressed no preference.  Overall, the group pathway provides a more cost 
effective approach in delivering low FODMAP education and an approach that was 
acceptable and satisfactory to most participants.   
However, there are still limitations and the main weakness is the design of the study. This 
study failed to assess any psychological or quality of life measures. As mentioned in the 
Section 2.1.5, such aspects are severe consequences of IBS and hence it is essential to 
measure anxiety, depression and/or quality of life for a new group delivery model. Instead, the 
study attempted to assess acceptability of the programme using patient interviews however 
the structure and questions asked were not specified and the analysis of these questionnaires 
were also vague. Another limitation is that patients were allocated into group education or 
one-to-one sessions based on their suitability during the initial telephone consultation, rather 
than by randomisation.  
2.4.2   Other dietitian-led dietary group education  
The evidence for group education session in IBS management is sparse, yet more research has 
been conducted in other dietitian-led dietary intervention that utilises group education. Type 2 
diabetes mellitus (T2DM) is a common and increasing chronic condition and similar to IBS, 
T2DM requires intensive dietary education, yet the number of patients requiring education is 
outstripping the numbers of dietitians to deliver it. Research assessing the effectiveness of 
group-based education compared with the traditional one-to-one dietitian consultation has 
found benefits in patient outcomes, including tighter glycaemic control fasting blood glucose 
levels, diabetes knowledge and treatment satisfaction (86-90). A group based T2DM 
education programme conducted in Australia looked at patient acceptability using semi-
structured interviews (91). Participants reported that the group session facilitated further 
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learning and increased motivated achieved through normalisation, peer identification or by 
talking with, and learning from the experiences in others. Such results support the use of 
patient centred programmes that use group interactions to meet the psychological needs of 
people diagnosed with same conditions and improve their motivations and behaviours. As 
IBS can be a debilitating as well as an isolating condition, the use of a group based education 
has the potential to enhance participant motivation and learning. As seen in other medical 
conditions that require dietary interventions, dietitian-led group education programmes have 
proven to be effective. Therefore, similar group service delivery models could be 
implemented into low FODMAP education.        
Conclusion  
Neither feasibility nor clinical effectiveness have been previously investigated when 
providing group education for low FODMAP advice in IBS patients in a New Zealand setting. 
Yet, there is emerging evidence to suggest that group based low FODMAP education has 
positive results. Hence, the present study aims to investigate the clinical effectiveness of low 
FODMAP education in patients with IBS and to explore the feasibility and patient 






Group based education for dietary interventions has the potential to be as clinically effective 
as well as more cost effective than traditional one-to-one dietitian consultations. In New 
Zealand, the demand for low FODMAP education outstrips the supply of registered dietitians 
able to deliver it, particularly in the public setting. The overarching aim of the study is to 
assess the feasibility and effectiveness of a dietitian-led low FODMAP education group 
session in Christchurch, New Zealand. Therefore, the objectives of this study are to: (i) 
examine the feasibility of group education in IBS patients referred from general practitioners 
within the Christchurch city area, (ii) to assess how the approach affects patients’ 
gastrointestinal symptoms and psychological states and (iii) to assess patients’ experiences 
and perspectives of the low FODMAP diet after attending the initial session.   
       3.1   Hypothesis  
We hypothesise that: (i) General practitioners in Christchurch will refer IBS patients to attend 
the sessions and participants will attend the sessions, (ii) Patients’ gastrointestinal symptoms 
and psychological state will improve as indicated by their SAGIS and HADS questionnaire 
scores (at baseline and follow up) and (iii) Patients will have implemented the low FODMAP 









Participants and Methods 
The study is a non-randomised, interventional pilot study, comprising of IBS patients referred 
by their general practitioners (GPs) who live within the Canterbury District Health Board 
(CDHB) catchment area in New Zealand. The study is a small scale, pilot study to determine 
the feasibility and clinical effectiveness of a dietitian-led low FODMAP group education 
programme. The free programme occurs in two sessions as low FODMAP education involves 
two stages: elimination phase and reintroduction/rechallenging phase. This study also aims to 
explore participants’ experiences of the low FODMAP diet.  
4.1    Ethics  
The study was approved by the Human Ethics Committee of the University of Otago in 
March 2018 (ethics committee number H18/002) (Appendix A). Further additions were made 
to enhance the study design and amendments were approved by the Human Ethics Committee 
in April and July (Appendix B). All subjects were given a participant information sheet 
(Appendix C) and gave written informed consent before entering the study (Appendix D). 
4.2   Participants   
4.2.1 Recruitment  
At the start of June 2018, the low FODMAP education sessions were advertised to general 
practices in the surrounding areas of the venues to be used for delivering the intervention 
(Cashmere and Halswell). A member of the research team phoned each general practice and, 
depending on their interest in participating, an information pack was sent out by email or post. 
The info pack contained brief information for both the GP and the patient and also a referral 
form (Appendix E, F and G). If interested, GPs were required to fill out the referral form and 
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return this by email or post. Each consenting participant was assigned a participant number. 
Participants were contacted by a research team member and notified of the group education 
session dates, time and venues and given a choice to choose which session they could attend.  
4.2.2 Eligibility criteria  
Eligibility included an IBS diagnosis with diarrhoea or IBS with alternating diarrhoea and 
constipation, negative blood tests for coeliac disease and participants had to be aged over 18 
years. Participants were excluded if they had co-existing coeliac disease, ulcerative colitis, 
Crohn’s disease, BMI of ≤18.5kgm
2
 or ≥ 35kgm
2
, unintentional weight loss, limited English 
comprehension, living in residential care or have had previous dietetic supervision on the low 
FODMAP diet, IBS with constipation only, Type 1 or Type 2 diabetes or bowel resection. 
Further details are found in the referral form (Appendix G). 
 
4.2.3 Participant Contact 
Consenting participants were contacted throughout the study by the research team using 
telephone calls, emails and text messaging for research purposes. An outline of participant 
contact throughout the study is shown in Table 5. Such purposes included reminders to return 
consent forms and questionnaires as well notifying participants of session dates. Participants 
who did not attend the first session were not contacted further. Participants who did not 
respond after multiple sources of contacts were utilised were also not contacted further. 
Participants that did not improve on the diet were notified that their IBS was most likely 











4.3   Study design  
The study was designed as a prospective observational pilot study in which 25 participants 
were recruited to attend one and/or two low FODMAP education sessions nine-weeks apart. 
Participants were divided into two different education groups based on their preference and 
each group included up to 13 participants. The first session was focused on the Elimination 
Phase and based on symptom improvement, the participants were invited to attend the second 
session which focused on the Reintroduction Phase. Assessment data were collected over 
three months; July 2018 to September 2018. Data collection included the questionnaires and 




Questionnaires 1  
(SAGIS and HADS 
questionnaires) 
Questionnaires 2  





1. Initial phone call to explain the study  
 
2. Information, consent forms and baseline questionnaires of SAGIS and HADs sent via mail to 
participants’ homes  
 
3. Reminder text for first session and completing and returning baseline questionnaires  
 
4. Phone call to determine if participants had found sufficient improvement on the low FODMAP diet 
and participants booked in to the second session 
 
5. Reminder text for second session and completing and returning follow up questionnaires  
 
Figure 2. Data Collection during the course of the study. 
Abbreviations: IBS; Irritable Bowel Syndrome, SAGIS; Structured Assessment Gastrointestinal Symptoms, HADS; 





4.3.1    Study intervention  
Figure 3 shows the stages of the nine week study intervention, which is discussed in detail in 
the following sections.  
4.3.2   Group education session  
The study conducted two education sessions in community centres in two different suburbs in 
Christchurch; Cashmere and Halswell. The community centres provided a projector, projector 
screen, HDMI cord, desk and chairs. Participants signed their names in an attendance book 
before leaving the session.  
The first group education sessions were held at the South Library, Cashmere and Halswell 
Centre, Halswell. A registered dietitian with experience in low FODMAP education delivered 
both group education sessions. The low FODMAP diet was taught primarily using a 
PowerPoint presentation (Appendix H). The first low FODMAP education sessions focused 
on the Elimination Phase and lasted approximately 90 minutes. The first session focused on 
what FODMAPs are and how they affect IBS symptoms. Then the dietitian explained what 
the low FODMAP diet is and how to eliminate FODMAPs from the diet. Discussion was 
given around common high FODMAP foods and how to replace them with low FODMAP 
alternatives and where to find these. She also talked about common difficulties people faced 
while being on the low FODMAP diet and how to address these. For example, using a garlic 
infused oil (low FODMAP) instead of using garlic. To engage the participants and make the 
sessions more practical, participants were asked to discuss a potential low FODMAP meal 
plan with each other and a label reading activity allowed the participants to examine the 
packaging of common foods to determine if they were low FODMAP or not. Participants 
were also encouraged to take photos of FODMAP friendly alternatives they might find useful.  







Figure 3. Study Intervention outline  
 
Participants follows the low FODMAP diet for six weeks (end of July to start of September) 
Group Education Session 2 (17/20
th
 September 2018) 
 Reintroduction and challenging FODMAPs education provided 
 Session focused on how to reintroduce and rechallenge FODMAPs safely and correctly 
 Reintroduction resources provided for participants to take home 
Participants commence the reintroduction phase  
Participants continue with the reintroduction phase. End of study.  
After six weeks of low FODMAP diet (start to mid-September) 
 Participants are assessed  whether low FODMAP diet has provided sufficient IBS symptomatic 
improvement  
 If IBS symptoms improved by ≥ 50%, participant required to attend Group Education Session 2  
 If IBS symptoms improve by < 50%, GP notified and IBS management returns to GP 
 Participants complete the second set of questionnaires and  return to research offices by mail 
 
Group Education Session 1 (23/24
th
 July 2018) 
 First set of questionnaires collected at session  
 Low FODMAP diet education provided. First session focused on Elimination Phase: 
eliminating the different FODMAP containing foods from the diet.  
 Low FODMAP diet resources provided for participants to take home 
 Participants commences the low FODMAP diet and continues for six weeks 
 
Recruitment (early June to mid July 2018) 
• Advertised low FODMAP group education sessions to GPs 
• GP's refer eligible and interested patients to study  
• Participant is sent participant information sheet and consent form to complete.  
• Participants are sent first set of questionnaires to complete and bring to the first group 




were mentioned during the presentation. Participants were advised to follow the diet for six 
weeks and return to their normal diet after.  
Participants were given a copy of the presentation slides to take home as well as a handout 
summarising the information taught at the session. The handouts had an extensive food list of 
foods to ‘Eat freely’, ‘Limit’ and ‘Avoid’. An example meal plan for breakfast, lunch and 
dinner was also provided. Some general healthy eating information was also given for 
participants to take home such as the ’Health eating, Active living’ booklet. Discussion was 
given around using evidence-based apps and websites to help with recipes and shopping such 
as the MONASH app, ‘A Little Bit Yummy ’website and ‘Healthy Food’ magazine/website. 
Participants were encouraged to go to the IBS Health Pathways or the MONASH website for 
further information on IBS and FODMAP.   
After six weeks, participants were telephoned by a member of the research team to determine 
if the diet provided sufficient symptomatic improvement in their IBS symptoms. Questions 
such as ‘Do you think your symptoms have improved with the diet?’ and ‘If so, could you put 
on a percentage on, how much do you think you have improved by?’ were asked to determine 
if the low FODMAP diet had provided sufficient relief. If their symptoms had improved by ≥ 
50%, they were invited to attend the second group education session. If the diet had not 
helped their IBS symptoms by ≥ 50%, then the participant’s IBS management was handed 
back to their general practitioner and a letter was sent to the participant and general 
practitioner notifying them of this. This cut off was used as it is used routinely in clinical 
practice by dietitians to determine whether patients have found sufficient improvement. 
The second low FODMAP education sessions were booked approximately nine weeks later. 
The sessions were held at the same centers as the first sessions. These sessions were led by 
the same dietitian as the previous sessions and the same educational approach was utilised. 
The PowerPoint of the second education session can be found in Appendix I. The second low 
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FODMAP education session focused on reintroducing and challenging different FODMAPs 
and lasted approximately 60 minutes. In the second session, the session began by explaining 
the importance of rechallenging. Then the process of rechallenging FODMAPs was taught in 
a step-by-step process. Firstly, participants were advised to challenge foods during the 
evening to avoid any disturbances during the day. Secondly, the timing of rechallenging was 
explained using the handouts given. This allowed for a ‘Challenge day’ three times during the 
week and space in between the days to monitor symptoms. Thirdly, participants were taught 
what quantities to challenge with, starting with a small dose and increasing to a large dose. 
And lastly, how to interpret the results of the challenges regarding if the FODMAP is a major 
trigger, tolerated in small doses or tolerated well.   
Participants were given copy of the presentation slides and a handout summarising the step-
by-step process of rechallenging to take home. Participants were also given a rechallenging 
schedule to fill out.  
4.3.3 Questionnaires  
The Structured Assessment of Gastrointestinal Symptoms (SAGIS) questionnaire were used 
to measure effectiveness before and after the implementation of the low FODMAP diet (30). 
The Hospital Anxiety and Depression Scores (HADS) were used to assess psychological 
mood and distress of participants before and after the intervention as a secondary outcome 
(39). Participants were required to complete the SAGIS questionnaire (Appendix L) and the 
HADS questionnaire (Appendix N) prior to attending the first education sessions. 
Participants were asked and reminded to bring the completed questionnaires to the first 
education session. Participants were given the second set of the same questionnaires at the 
first education session and asked to complete them after following the low FODMAP diet for 
a minimum of six weeks. After they had completed the second set of questionnaires, 
participants were required to return the completed questionnaires by mail to research offices. 
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Clear written instructions regarding how to complete the questionnaires were displayed at the 
front and average amount of time taken to complete both questionnaires was 15-20 minutes. 
The SAGIS questionnaire uses a five-point rating scale (no problem=0, mild=1, moderate=2, 
severe=3 and very severe=4) (Appendix L) (30). The HADS questionnaire contains 14 items 
which is split into two domains; anxiety and depression and utilises a four-point rating scale 
(Appendix N) (39).  
4.3.4 Semi-structured interview 
At the end of the six week low FODMAP diet period, participants who attended the first 
group education session were contacted for a telephone interview conducted by the candidate. 
Before commencing the interviews, consent was obtained to digitally record the interview. 
The interviews aimed to assess the participant’s acceptability and attitudes towards the 
feasibility of following a low FODMAP diet. Participants were also asked to evaluate the 
group education sessions and resources provided. Table 6 provides an overview of the semi-
structured interview protocol. On average, the interviews lasted approximately 10 minutes. 
All interviews were transcribed verbatim by the candidate. A thematic inductive approach was 
used to identify broad themes across the data set (92). Following the ‘Phases to thematic 
analysis’ by Braun and Clarke, the candidate familiarised herself with the data set, coded 
aspects of the data deemed pertinent to the research aim and then the codes were collated into 







Table 6. Overview of the semi-structured interview protocol  
Overview – ease of diet  
How did you find the low FODMAP diet? 
What aspects did you find easy? 
What aspects did you find hard? 
Why did you think the low FODMAP diet didn’t work for you? 
How come you didn’t implement the low FODMAP diet? 
Did the positives of the diet outweigh the negatives? 
Challenges of the low FODMAP diet 
What were some of the challenges you experienced with the low FODMAP diet? 
Could you tell me a bit more about the challenges? 
How did you overcome these challenges? 
Were your family supportive of you being on the low FODMAP diet? Did you face any challenges with the 
family dynamic? Did you end up having to cook separate meals for yourself and your family? 
Did the low FODMAP diet cost you more than your usual diet? Or was it more or less the same? Which items 
were costing you more?  
Education sessions and resources provided 
How did you find the session?  
If we were to do it next year, what are some improvements you would like to see?  
In terms of the challenges you faced, was there anything you would change in the class to help to address 
these challenges?  
Did you use any of the resources provided by the session? If so which ones and how did you use it to help 
you?  
Did you use any of the websites or apps mentioned at the session? If so which ones and how did you use it 
to help you? 
If not, what other resources would you have liked to see?  
 
4.3.5 Session evaluation forms  
Participants were required to complete an evaluation form at the end of each session 
(Appendix M). This evaluation form is protocol for any CDHB programme or session.  
Participants are asked to report back on what they thought of the session overall, time of day 
and parking amongst other factors. This study will look briefly into these results however 




4.4 Statistical analysis  
Information  from the SAGIS and HADS questionnaires was analysed using the statistical 
software programe; IBM SPSS Statistics 25 (1998,2017, USA). Changes in SAGIS 
questionnaire scores were assessed using paired t-tests as a measure of effectiveness of the 
low FODMAP diet taught in a group setting. HADS scores were separated into their domains: 
anxiety and depression. Anxiety and depression scores were then analysed using a chi-squared 
test to determine statistical signficance (p<0.05). Paired t-test of anxiety and depressions 
scores were also performed.  However, as this is a feasibility study involving a small sample 
size it was not designed, or adequately powered to test clinical significance but only 
numerical signficance and thus a cautionary approach has to be taken when drawing 












5.1   Pilot study: What was planned versus what happened   
5.1.1 Recruitment  
The initial plan was to recruit participants from GP referrals from the surrounding areas of the 
venues. Approximately, ten referrals came from the general practices in the surrounding area 
of the venues; seven referrals came from Cashmere Health and three from Halswell Health. 
Due to low referral rates, Canterbury Initiative (CI) members attempted to recruit from 
Christchurch Hospital, from where a gastrointestinal dietitian referred three participants. 
However, these participants were excluded as they had constipation predominant IBS. A 
further 15 referrals were made through additional recruitment methods. The study was 
promoted on the home page of Community HealthPathways and HealthInfo Canterbury and 
also promoted by the Canterbury Initiative leadership team on their practice visits. The study 






The second education sessions were scheduled to be at the same community centres and same 
times as the first education sessions. However, the room booked at Halswell Centre was 
undergoing renovations and could not be used. A room was then booked at South Library and 
therefore both second education sessions were booked at South Library. However, due to 
Figure 4. Pegasus Health advertisement on e-newsletter 
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numbers and participant availability, an evening session was offered and one of the sessions at 
South Library was cancelled. The evening session was held at Oxford Terrace and 
participants were notified of the time, date and parking availability by text and phone call. 
There was a CI member waiting at the entrance to let people in.  
5.1.3 Questionnaires  
Getting participants to complete and return the follow-up questionnaires via mail proved to be 
difficult and time consuming. Participants were telephoned and given text reminders, yet the 
time taken for questionnaires to be returned took two to three weeks longer than expected. 
Some participants had lost their questionnaires and these participants were sent electronic 
copies of the questionnaires to complete via email.  Three participants completed electronic 
copies. 
5.2 Main results  
5.2.1  Recruited participants  
A total of 25 referrals were made and approximately 40% (10) of referrals came from general 
practices in surrounding areas of the venues and 60% (15) of referrals came from other types 
of promotion. Recruitment began in late June and ended July with the last participant being 
recruited on the 21st of July 2018. Recruitment and attendance numbers throughout the study 
is shown in Figure 5. 
 5.2.2  Baseline characteristics of  study participants  
Baseline characteristics of study participants are shown in Table 7. Participants ranged in age 
from 19 to 57 years.  Seventy-seven percent of participants were female and all participants 
identified as New Zealand European. The majority of participants were overweight or obese 
(68.4%). Most participants identified as having either diarrhoea predominant IBS (45.5%) or 
mixed constipation and diarrhoea predominant IBS (40.9%). Almost all participants were 































Total number of participants recruited 
n= 25 
 
3 dropped out as they 
could not attend the 
session dates and times  





Total number of 
participants who did not 
follow the low FODMAP 
diet 
n=2 
Total number of participants 
who attended the first session 
n=17 
Total number of participants 
who experienced < 50% 
improvement in IBS symptoms 
n= 2 
Total number of participants 
who experienced ≥50% 
improvement in IBS symptoms 
n= 13 
Total number of participants who 
attended the second session 
n= 11 2 DNAs  





Figure 5. Total number of participants from recruitment to final analysis stage.  
 Notes: n; number of participants, DNA; did not attend, FODMAP; Fermentable Oligosaccharide Disaccharide 
Monosaccharide and Polyols, IBS; irritable bowel syndrome.  
Total number of participants 





















Characteristics Number of Participants 
n=22 
Age, mean in years 34.5  
Gender  
Female 17 
Male  5 
Ethnicity    
New Zealand European  22 
Other   0 






Overweight (25.00 – 29.99kgm
2
) 7 
Obese Class I (30.0-34.99kgm
2
) 5 
Obese Class II (35.00-39.99kgm
2
) 0 





   
IBS with predominant diarrhoea  10 




Headaches  15 
Chronic fatigue 6 
Back pain 9 
Depression 10 
Sleep disturbances  9 
Anxiety disorders  11 
Referral  
General practitioner  20 
Other health professional  2 
Abbreviations: n; number,  BMI; body mass index (weight (kg) divided by height squared (m)2 ) 
a n=19. Two participants did not have heights recorded for BMI to be calculated 
b n=19.  Two participants were able to be contacted to determine IBS subtype 






5.1.3 Attendance at the first session  
Attendance at each of the sessions is shown in Figure 5. A total of 25 participants were 
recruited into the study. Out of the 25 participants, three participants dropped out of the study 
as they could not attend the session dates. Seventeen participants attended the first education 
sessions while six participants did not attend (DNAs). At the first education session, 10 
participants attended the Cashmere venue and seven participants attended the Halswell 
session, resulting in an attendance rate of 77.3% in the first education sessions (Elimination 
Phase), of those initially recruited. 
Out of the five DNAs, three participants were contacted about their non-attendance. One 
participant reported that they had not received any information regarding the education 
sessions, one participant said they could not take time off work and another participant 
reported that they were called into work unexpectedly. The participants that did not attend 
shared similar characteristics, four of the participants being under the age of 25 and three of 
the participants had a BMI < 30kgm
2
. 
5.1.4 Symptomatic improvement  
All participants that attended the first education were contacted by a member of the research 
team seven to eight weeks after the first education session. Overall, 76.5% of participants 
reported ≥ 50% improvement in their IBS symptoms. 11.7% of participants reported that their 
IBS symptoms had improved by 100%, 11.7% of participants reported their IBS symptoms 
had improved by 80% to 100%, 41.2% of participants reported their IBS symptoms had 
improved by 60% to 80% and 11.7% of participants reported their IBS symptoms had 
improved by 50% to 60%. In total, four participants (24%) reported no improvement. Out of 
the four that did not experience any improvement, two participants reported their IBS 
symptoms had not improved at all and two participants reported that they did not implement 
the diet at all.  
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5.1.5 Attendance at the second education session 
Attendance at the second education session is demonstrated in Figure 5. Out of the 13 
participants whose symptoms had improved, 11 (85%) participants attended the second 
education session (Reintroduction Phase). Originally, the second education sessions were to 
be held at the same venues as the previous education session. However, Halswell Centre was 
undergoing renovations and could not be used. Hence, another session was booked at South 
Library instead. However, due to the smaller numbers, the research team decided it was best 
to conduct only one education session at South Library, Cashmere which was held on the 17
th
 
of September from 10am to 11am. Three participants reported that they were unavailable 
during the day time and an evening session was offered. The evening session was conducted 
on Thursday 20
th
 of September from 7.00pm to 8.00pm was at 32 Oxford Terrace, 
Christchurch Central. Overall, ten participants attended the second education session at South 
Library, Cashmere and one participant attended the Oxford Terrace session as two 
participants did not end up attending.  Overall recruitment and attendance numbers is 
demonstrated in Figure 6. 
5.3 Clinical effectiveness of group education 
A total of 32 SAGIS questionnaires and 31 HADS questionnaires were collected throughout 
the study. Figure 6 summarises the data collection process from the beginning to final data 
analysis. Participants were excluded from final data analysis if they did not attend the first 
education session or if they did not implement the low FODMAP diet for a minimum of six 
weeks. Initially, a time period of two weeks was allocated for questionnaires to be completed 
and returned to the research team. However, only a small number of questionnaires had been 
received by the two-week period so the data collection period was extended for another two 
weeks. The total data collection period ended at approximately four weeks with the first sets 
of questionnaires received in early September and the last set of questionnaires received on 
the 5
th
 of October.  
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The candidate utilised a variety of communication devices such as text messaging, emailing, 
voice messages and phone calls to remind participants to return their questionnaires. Those 
who had not returned their second set of questionnaires were offered electronic copies of the 
questionnaires to complete and return via email. Two participants filled out their 
questionnaires electronically and one participant scanned and emailed their completed 
questionnaires via email.  
5.3.1 Results of SAGIS questionnaire  
Table 8 summarises the mean scores of the 24 variables in the SAGIS questionnaire of the 
participants. Overall, all means scores for each of the variables decreased after 
implementation of the diet. Nineteen variables (79.2%) showed statistical significance 
(p<0.05) with the greatest change in bloating being 3.00 (0.894) at baseline and 1.09 (0.701) 
after intervention. Belching, dysphagia, early satiety, loss of appetite and vomiting showed no 
statistical significance. Figure 7 demonstrates SAGIS mean scores and the standard error of 
the mean scores. 
5.3.2 Results of HADS questionnaire  
At baseline, seven participants (64%) had anxiety and three participants (27%) had depression 
according to the HADS questionnaire. At follow- up, three participants (27%) had anxiety and 
one participant (9%) had depression according to the HADS questionnaire. Results from chi-
square tests shows that there was no statistically significant differences for both anxiety 
(p=0.087) and depression (p= 0.269) cases at baseline and follow-up.  
 
Table 9 and 10 summarises the mean scores HADS questionnaire in their separate domains: 
anxiety and depression. Most anxiety variables decreased from baseline to follow-up, 




















Total number of 
participants recruited 
n= 25 
Total number of participants 
booked to attend the session 
n=22 
Total number of questionnaires sent 
out to participants 
 
n= 22 SAGIS n= 22 HADS 
4 drop outs  
‘Before implementing the low FODMAP diet’ 
questionnaires (#1) completed and received 
n= 18 SAGIS n= 18 HADS  
Total number of participants who 
attended the first session (low FODAMP 
implementation education) 
n= 17 
1 SAGIS and 1 HADS 
questionnaire 
excluded as patient 
did not attend the 
first session  
2 SAGIS and 1 HADS 
questionnaire 
excluded as they did 
not implement the 
diet 
2 SAGIS and 2 HADS 
questionnaires was 
never received  
 
‘After implementing the low FODMAP diet’ 
questionnaires (#2) completed and received 
n=14 SAGIS n=13 HADS 
Final data analysis 
n= 11 SAGIS n= 11 HADS 
Figure 6. Total number of participants from that completed final data analysis. 
 Notes: n number, FODMAP Fermentable Oligosaccharide Disaccharide Monosaccharide and Polyols, HADS 
Hospital Anxiety and Depression scores, SAGIS Structured Assessment Gastrointestinal Symptoms Scale 
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frightened feeling like ‘butterflies’ in the stomach’ at baseline 1.82 (0.752) and after 
intervention 1.09 (0.701) and ‘I get sudden feelings of panic’ at baseline 1.64 (0.809) and 
after intervention 0.91 (0.701). The correlation and t-value for ‘I feel restless as if I have to be 
on the move’ was also unable to calculate for this variable as standard error was zero. 
Similarly, depression variables decreased from baseline to follow- up, however only three 
were shown to be statistically significant (p<0.05). These were ‘I still enjoy the things I used 
to enjoy’ at baseline 1.00 (0.632) and at intervention 0.55 (0.522), ‘I feel as if I am slowed 
down’ at baseline 1.91 (0.944) and at intervention 1.18 (0.751) and ‘I can enjoy a good book 
or radio or TV programme’ at baseline 0.91(1.221) and at intervention 0.27 (0.674).  
Figure 8 and 9 demonstrate mean differences of the individual anxiety and depression 



















Variable  Before low FODMAP 
diet  
Mean (SD) 
After low FODMAP diet  
Mean (SD)  
Δ  p-value  
Belching  0.55 (0.688) 0.18 (0.405) 0.364 0.167 
Dysphagia  0.18 (0.122) 0.09 (0.091) 0.091 0.341 
Fullness  1.64 (0.809) 0.73 (0.786) 0.909 0.010* 
Early satiety  0.73 (0.195) 0.36 0.505) 0.364 0.167 
Postprandial pain  1.45 (0.934) 0.55 (0.688) 0.909 0.016* 
Epigastric pain 1.55 (1.036) 0.36 (0.505) 1.182 0.007* 
Retrosternal discomfort  0.91 (0.944) 0.27 (0.467) 0.636 0.046* 
Pain before BM 2.45 (0.934) 0.91 (0.831) 1.545 0.001* 
Pain after BM  2.30 (1.059) 0.80 (0.789) 1.500 0.005* 
Difficulty to empty BM  1.91 (1.221) 1.00 (0.894) 0.909 0.043* 
Constipation 1.73 (1.191) 0.64 (0.674) 1.091 0.006* 
Hard BM  1.55 (1.214) 0.45 (0.522) 1.091 0.025* 
Loose BM  2.73 (1.272) 1.09 (0.831) 1.636 0.003* 
Incontinence  0.91 (0.944) 0.09 (0.302) 0.818 0.011* 
Urgency to empty BM  2.82 (1.168) 1.27 (0.647) 1.545 0.001* 
Diarrhoea 2.18 (1.401) 0.91 (0.539) 1.273 0.005* 
Loss of appetite 0.73 (1.104) 0.27 (0.647) 0.455 0.138 
Abdominal cramps  2.09 (1.136) 0.73 (0.786) 1.364 0.013* 
Sickness  1.09 (1.044) 0.27 (0.467) 0.818 0.020* 
Nausea 0.73 (0.905) 0.09 (0.302) 0.636 0.011* 
Vomiting  0.27 (0.467) 0.00 (0.000) 0.273 0.082 
Bloating  3.00 (0.894) 1.09 (0.701) 1.909 0.000* 
Excessive gas  2.64 (1.027) 0.82 (0.982) 1.818 0.002* 





*p-value of <0.05 is considered statistically significant  
Table 8. Paired sample t-test results from SAGIS before and after questionnaires  
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After low FODMAP diet  
Mean (std dev)
 
Δ  p-value  
I feel tense or ‘wound up’ 
 
1.82 (0.874) 1.45 (0.688) 0.364  0.167 
I get a sort of a frightened 
feelings like something awful is 
about to happen   
 
1.64 (0.924) 1.36 (0.505) 0.273 0.341 
Worrying thoughts go through 
my mind  
 
2.00 (1.095 1.45 (1.293) 0.545 0.111 
I can sit at ease and feel 
relaxed  
 
1.27 (0.647) 0.91 (0.539) 0.364 0.167 
I get  a sort of a frightened 
feeling like ‘butterflies’ in the 
stomach  
 
1.82 (0.752) 1.09 (0.701) 0.727 0.038* 





   
I get sudden feelings of panic  
 
1.64 (0.809) 0.91 (0.701) 0.727 0.012* 




After low FODMAP diet  
Mean (std dev)
 
Δ  p-value  
I still enjoy the things I used to 
enjoy  
 
1.00 (0.632) 0.55 (0.522) 0.455 0.016* 
I can laugh and see the funny 
side of things  
 
0.73 (0.786) 0.82 (0.751) -0.091 0.676 
I feel cheerful  
 
0.82 (0.874) 1.00 (0.894) -0.182 0.588 
I feel as if I am slowed down  
 
1.91 (0.944) 1.18 (0.751) 0.727 0.038* 
I have lost interest in my 
appearance  
 
1.55 (1.128) 1.09 (1.136) 0.455 0.053 
I look forward with enjoyment 
to things  
 
0.82 (0.751) 0.36 (0.674) 0.455 0.053 
I can enjoy a good book or 
radio or TV programme  
 
0.91 (1.221) 0.27 (0.674) 0.636 0.046* 
Table 9. Paired sample t-tests of results of HADS questionnaire: Anxiety    
*p-value of <0.05 is considered statistically significant. 
a
 The correlation and t value cannot be computed because the standard error of the difference is 0. 




















































I feel tense of 'wound 
up'  
I get a sort of frightened 
feeling as if something 
awful is about to happen  
Worrying thoughts go 
thrpugh my mind  
I can sit at ease and feel 
relaxed  
I get a sort of frightened 
feeling like 'butterflies' 
in the stomach  
I get sudden feelings of 
panic  



















I  still enjoy the things I
used to enjoy
I can laugh and see the
funny side of things
I feel cheerful I feel as if I am slowed
down
I have lost interest in my
appearance
I look forward to things
with enjoyment to things
I can enjoy a good book
or radio or TV program
Figure 9. Comparison of HADS depression means (SEM) from baseline to follow-up  
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5.4 Acceptability of the low FODMAP diet (semi-structured interviews) 
Results from the telephone interviews showed a range of benefits in group education and the 
general response from participants about the low FODMAP diet were positive. Most 
participants felt that the information provided at the session was sufficient for them to 
implement the low FODMAP diet for six weeks. Common words participants used to describe 
the sessions included ‘straightforward’, ‘really good’, ‘informative’, ‘well covered’ with one 
participant describing it as ‘short of someone cooking for me’.  Table 11 shows a summary of 
the main and sub themes identified. The next sections explore the themes in greater detail in 
regards to facilitators, barriers and attitudes towards group education.  
 
 
Main theme  Sub-themes  
A new way of eating  
 
Meal planning  
Time to prepare and plan meals  
Regular meal pattern 
Monitoring FODMAP intake  
Cooking from scratch 
 
Replacement of foods 
 
Replacement of high FODMAP foods with low FODMAPS alternative  
Using alternative flavourings instead of garlic and onion  
 
Eating out  Maintaining social norms  
Uncertainty of FODMAP content in meals eaten away from home  
 
Social support  Understanding from family and friends 
Reinforcement and encouragement from partners/spouse 
Group education and other participants  
 
Resources  Using a readily available app on the go (i.e. MONASH low FODMAP 
app) 
Using websites (e.g. A Little Bit Yummy) for recipe ideas  
Low FODMAP take home resources provided at the session  
 
Label reading  Ease of reading and interpreting nutrition information  
Aids to label reading – Monash low FODMAP diet app  
 
Table 11.Summary of themes derived from semi-structured interviews  
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5.4.1 Facilitators   
Participants expressed a change in their relationship with food and eating; one expressed that 
they ‘definitely changed some of my thinking’ and another ’I’m more aware what I’ve been 
eating but also how I’ve been eating’. More effort and research into shopping lists, meal 
planning and meal preparation was adapted by participants which aided them to successfully 
follow the low FODMAP diet for six weeks. Most of participants used the ‘A Little Bit 
Yummy’ website and the few that purchased the Monash app found its accessibility and 
convenience to be very helpful: ‘I downloaded the app, the FODMAP app, it sort of gave me 
enough products on there to give me an idea’. Another participant favoured its convenience 
saying that ‘MONASH one was the first port of call mainly because I had the app and I find it 
easy to find things on it’. However, the FODMAP app costs $11.99 (NZD) and the cost of this 
proved to be a barrier for one participant. ‘A Little Bit Yummy’ and the MONASH app were 
recommended by the presenting dietitian, however participants also sought other sites for 
further information. One participant found another website –‘The Wild Gut Project’ which 
catered to vegans with IBS.  Another said ‘There were a few things I wasn’t sure about that I 
googled and I you know pick something that looks reputable to see’.  
Replacing one product for a low FODMAP alternative was a common approach to reduce 
FODMAP intake. Most participants agreed that finding low FODMAP alternatives for foods 
that they often ate was really helpful. Though the low FODMAP alternatives for bread and 
lactose-free milk tended to be more expensive, the cost did not hinder many participants from 
purchasing them as many reported the increase in shopping costs to be minimal. Participants 
found these food swaps to have little disruption to their usual eating: ‘Only challenge was 
probably bread considering I had like sandwiches for lunch cause that was easy but then 
having that low carb one’. Another participant emphasised the need for finding alternatives: ‘I 
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might have chutney a few times a week which I couldn’t have but I found that I could use red 
pepper jelly instead, just finding alternatives really’. 
 
Other main facilitators expressed were the use of the resources as well as having a supportive 
partner. The take home resources were used by most participants, a few read through the 
material once but most repeatedly revisited it. Most participants found the extensive food lists 
in the handouts to be very useful because it helped them easily identify what foods to eat in 
accordance with a low FODMAP diet. Most participants found the extensive food list to be of 
great help, especially in the beginning when they were starting the diet: ‘When I left there was 
nothing to eat but then when I started looking through everything myself it was fine’. Having 
a supportive partner or family also helped participants to follow the diet, in some cases 
allowed for team work and collaboration. One participant expressed that he and his partner 
worked together to create a two-week cycle low FODMAP menu: ‘Got easier sort of maybe 
going through a bit of a 2 week cycle with meals and stuff at that at the moment we’ll just go 
sort of a two week plan that works and just change it up’. 
 
5.4.2 Barriers  
Behaviour change and dietary modifications proved to be the biggest challenge for almost all 
participants. One participant expressed that ‘It was harder at the beginning but towards the 
end it was quite simple now really’ which was a sentiment reflected throughout participants 
with another saying that ‘(it was) really just changing my habits’.  
 
Another common challenge that participants faced included social gatherings and eating out. 
One participants said that she ‘kind (of) just wanted to fit in with other people’ and another 
participant found distraction at social gatherings to be problematic ‘It was being distracted 
more than anything, conversations happen and you get into some pretty intense discussions 
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and then you go hang out what was that’. ‘The garlic and onion scenario’ was a common 
challenge that participants came across both at home and eating out. Participants expressed 
that going out to eat or getting takeaways was difficult, due to the lack of garlic and onion free 
alternatives. However, some participants believed that the diet ending up costing them less as 
they were less inclined to eat out or buy takeaways for the same reason. Some participants 
expressed that cooking at home was also difficult, ‘It was just more realising how much garlic 
and onion were in things’. Common foods that participants struggled with included pasta 
sauce, hummus and soups. One participant expressed that ‘It was more a combination of 
ingredients that you had to good in with a fine tooth comb that was a real struggle’ which 
was expressed across most individuals. 
 
Another challenge that participants encountered the graded amount of FODMAPs they could 
have at one given time, an example a participant gave was ‘Like sure I can have 10 almonds 
but when is the next time I can have ten almonds’. One participant said that she was unsure of 
the different portions of FODMAP containing foods in one serving-- ‘It might be a green light 
food but when you have it in a certain quantity or if you have it with another low FODMAP 
food and another low FODMAP food becomes an orange light’.  
Those who did not complete or implement the diet at all, reported that personal issues were 
the main reason. One participant expressed that she had multiple food allergies and lacked 
confidence to implement the diet safely. Another participant identified his lack of motivation 
as his main barrier: ‘At this stage, I am not motivated enough to do the diet’ and when asked if 
he thought the sessions were helpful he replied ‘They were probably helpful it’s probably, 
more me understanding what I can and can’t eat’. 
 
When participants were asked ‘If there were any improvements that could be made to the 
session’ most participants could not think of any suggestions. One participant wanted more 
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interaction with the rest of the group; ’It’ll be cool to stay in touch with the other people in the 
group as well just touch base with how’s everyone else is going and (how) the other people 
might have gone’. Another participant suggested more complete food lists and more 
information about the hidden FODMAP ingredients in products because ‘If the information 
that you give us isn’t complete then it gets confusing and conflicting’. Furthermore, another 
wanted to see more information about alcohol in a low FODMAP diet.  
 
5.4.3 Attitudes and perspectives around the programme  
Overall, the group education sessions were well received by the participants. Participants who 
found that their symptoms have improved on the low FODMAP diet, when asked ‘Did the 
positives outweigh the negatives?’ all participants replied with ‘Yes’. After completing the 
diet, most participants were grateful to part of the group education experience and content 
with the overall results of the low FODMAP diet- ‘The rewards of actually doing it are very 
high’ and another expressing that ‘The (low FODMAP) diet has given me more control’. One 
participant said that ‘Following these sessions pretty sure I will go back to full time work next 
year. So I’m very grateful for that’ and another spoke highly on the group setting – ‘Other 
people that are doing it and more connection with other people that are doing it too’. 
5.5 Acceptability around the programme (Eval Forms) 
The session evaluation forms show that participants thought highly of education programme 
in general. Scores for ‘Time of day’, ‘Parking’, ‘Meeting room’, ‘Acoustics’, ‘Handouts’ and 
‘Session overall’ were rated highly across all four education sessions conducted. On the scale 
of 1 being below average to 5 being excellent, the lowest rated variable was ‘Parking’ which 
was rated 4.17 out 5. The second lowest rated variable was for ‘Time of day’ which was rated 
4.3 out of 5. These high scores support the overall positive experience of participants as 
suggested in the telephone interviews.  As mentioned in the previous chapter, evaluation 





   6.1 Summary of key findings  
This present study is one of the first to formally evaluate a dietitian-led low FODMAP group 
education programme for the dietary management of IBS. The results demonstrate that 
dietitian-led low FODMAP group education is feasible and effective in the management of 
IBS.  
6.2 Clinical effectiveness  
Our findings support previous results from randomised controlled trials that show that the low 
FODMAP diet provides relief in common gastrointestinal symptoms experienced by IBS 
patients (Table 2). Furthermore, the findings of the present study show that a group delivery 
of the low FODMAP diet can be effective in providing the desired symptomatic relief. The 
study found a statistically significant improvement in gastrointestinal symptoms in 
participants after following the low FODMAP diet. Significant improvements were seen in 
almost 80% of SAGIS variables (19/24). Such findings support those of Whigham et al, the 
first to formally evaluate group education for the delivery of the low FODMAP diet (20). In 
their study, 54% of participants were satisfied with their gut health at the end of intervention. 
Comparatively, in our study 87% (13/15) of participants were satisfied with their 
symptomatic improvement at the end of intervention. Most gastrointestinal symptoms such as 
bloating, abdominal pain and flatulence significantly improved apart from belching, which is 
similar to our current findings. Whigham et al also compared the clinical effectiveness of 
dietitian-led group education to traditional one-to-one pathway. They concluded that 
improvement in IBS symptoms is irrespective of the type of education delivery (group versus 
one to one). Though our study did not use a comparator group, the results of our study 
compared to those that utilised an individualised delivery model suggest similarities 
6 
Discussion and Conclusion 
65 
 
comparable to the findings from Whigham et al. Similar symptomatic improvement can be 
found in both types of delivery; bloating, loose bowel motions, stool consistency and 
flatulence before and after implementation of the low FODMAP appear to be consistently and 
significantly improved regardless of delivery model (15, 17, 18, 94). Early satiety, belching, 
dysphagia, vomiting and loss of appetite showed no significant difference at baseline and 
follow-up which is consistent with previous research as these symptoms are rarely associated 
with IBS. 
 
A positive effect of the group low FODMAP education programme on psychometric and 
psychosocial measures is also shown in this study. Whigham et al failed to look at the 
psychological component in those living with IBS is a very important measure of health and 
wellness. As IBS has no structural or objective component, one must rely on patient reported 
illness experiences and their perceived feelings and emotions becomes a very important 
measure in assessing patient’s health status. The current literature has differing viewpoints on 
the impact of IBS group education on anxiety, depression and health-related quality of life 
(HRQoL). As shown in Chapter 2, Section 2.1.5, individualised dietary education and 
counselling improves patients’ understanding of IBS and their dietary management of IBS 
and hence their overall mood and HRQoL. However, others suggest that having group 
interactions allow patients to interact, relate and share salient ideas and experiences. Overall, 
there is limited and conflicting literature concerning IBS group dietary education and the 
impact it has on quality of mood and mental disorders, quality of life. 
 
Like many other psychometric measurements, the HADS questionnaires utilises valid and 
methodological properties, the results of the questionnaire remain subjective within patients’ 
perceived feelings and self-reported illness (39). Additionally, 50% of participants reported 
having an anxiety and 45% reported to have depression prior to entering the study.  
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Anxiety and depression scores did not improve as remarkably as gastrointestinal symptom 
scores which are to be expected given the nature of the intervention and pre-existing 
psychological disorders. Positive changes in mood and mental factors often take a longer 
length of time to provide significant improvement (95). Furthermore, mental health requires 
long term behavioural therapy, medications and other strategies besides dietary management 
and a longer follow- up period may demonstrate more positive changes in mental health and 
hence HADS scores. Overall, HADS scores were only a secondary outcome in our study and 
it is more appropriate to evaluate the feasibility and effects of a group education programme 
in a multifactorial context through attitudes and shared experiences about the low FODMAP 
diet, GI symptom severity as well as psychosocial distress.  
6.3 Patient acceptability of low FODMAP group education  
 
Results from the telephone interviews showed that participants were generally positive and 
grateful for the overall experience of the low FODMAP diet. Additionally, participants found 
the group education programme to enhance their understanding and acceptability of the low 
FODMAP diet. Our results are in accordance with other IBS or non-IBS group dietary 
interventions, which also demonstrated that group settings increase patients’ acceptability of 
the treatment through sharing of experiences as well as comradery with other patients (20, 87-
90, 96). Furthermore, suitable educational resources as well as references to websites and 
apps also increased adherence and acceptability of the low FODMAP diet which is consistent 
among emerging literature (16, 20, 85, 97). Websites and web apps such as ‘A Little Bit 
Yummy’ and the ‘Low FODMAP Diet App (MONASH)’ are increasing in popularity as they 
provide a fast and accessible platform for FODMAP friendly meals and products. However, 
the increase in web based education creates uncertainty and vulnerability for evidence based 
low FODMAP advice and individuals without the necessary expertise to do so. More research 
and protocol established should be warranted regarding the efficacy and safety of emerging 




Those who did not implement the diet after attending the initial session expressed that they 
had personal and individual reasons for not doing so. Suggesting it was not due to the delivery 
of intervention, but rather personal reasons. This also highlights the need to screen those 
suitable for one-to-one delivery rather than group delivery. Whigham et al employed a triage 
system using a telephone screening clinic to allocate participants’ suitability for group versus 
one-to-one education. They emphasised the importance of flexibility and being able to offer a 
one-to-one session to ensure effective patient care and maintain patient choice. Non-formally 
evaluated and unpublished results of a dietitian led low FODMAP group education 
programme at Christchurch Public Hospital also emphasised the need for a more vigorous 
screening process. Though our study employed a strict exclusion criterion, a telephone 
screening may be more useful to identify those participants who require a personalised dietary 
counselling such as those with complex mental health issues, lack of motivation, dietary 
restrictions and food allergies.  
 
Participant acceptability regarding the overall logistics and organisation of the programme 
were also positive. To our knowledge, this study is one of the few that assessed accessibility 
to the programme as well as acceptability of the treatment. Whigham et al looked at 
attendance rate as their only measure of accessibility. However, in a feasibility study it is 
important to look at the wider picture in regards to how participants found the overall 
experience of the programme. Participants reported that the ‘timing of day’ to be an issue as 
most participants had to take time off work and some participants not being able to attend the 
sessions due to other commitments during the day. The low FODMAP group education 
programme should be flexible in terms of offering a one-to-one versus a group pathway as 




6.4 Strengths and weaknesses 
This is the first study to examine the feasibility of low FODMAP group education for adults 
with IBS in a New Zealand population. The mixed methods design meant it was possible to 
assess gastrointestinal symptoms as well as psychological measures at baseline and at the end 
of intervention, as well as achieve a greater understanding of participant’s experiences and 
attitudes obtained through semi structured telephone interviews and evaluation forms. The 
candidate conducted the majority of data collection of the questionnaires and telephone 
interviews to remove inter-investigator variation.  
 
There are a number of limitations. Our quantitative data needs to be viewed with caution and 
interpreted in context with the weaknesses of the study. As the study was small in size, it is 
not powered to demonstrate clinical significance. Yet, the results are promising and has 
potential to show clinical effectiveness given a larger sample size. Another limitation of the 
study is that we did not assess the cost of the group delivery model.  Yet it can be assumed 
that the cost of a group delivery model is likely to cost significantly less than the cost of one-
to-one session for each participant. Our study is based in Christchurch which means that the 
results are applicable to the context of Christchurch. In a more ethnically diverse city such as 
Auckland, language barriers, culture around food and different types of cuisines may need to 
be addressed. Furthermore, we only included IBS-D or IBS-M participants as IBS with 
constipation was deemed less appropriate for this study.  
 
6.5 Future research  
Our study focused primarily on the low FODMAP diet and the Elimination Phase as the main 
source of dietary treatment. However, the purpose of the low FODMAP diet is to allow 
patients to identify their food triggers through reintroduction and then modify their diet 
accordingly for long term symptom management. Future research should investigate the 
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feasibility of a low FODMAP group education in terms of reintroduction and diet 
modification. Our study excluded patients with IBS-C. Future research into low FODMAP 
group education for patients with IBS-C is warranted given the current findings are positive 
and promising. Future studies should also look at the importance of a vigorous triage system 
to screen suitable group education patients. They should assess the necessary questions and 
topics to discuss in order to appropriately screen participants. With New Zealand’s changing 
multicultural landscape, future studies should also look into the feasibility and acceptability of 
an ethnically diverse group of participants. 
 
6.6 Conclusion 
This six week, group-based low FODMAP education programme was feasible in improving 
adult IBS patients with diarrhoea or diarrhoea and constipation. Gastrointestinal symptoms as 
well as psychological states were improved from baseline to follow up. Participants were 
generally positive and satisfied with the education provided at the sessions. Participants also 
expressed that the timing of the day time sessions could be better improved. Main challenges 
faced when implementing the low FODMAP diet included eating out, combination of 
different FODMAPs in meals and eliminating onion and garlic from the diet. The main 
facilitators were: supportive peers, handouts given at the session and using websites or the 





Application to Dietetics 
 
Irritable bowel syndrome is a chronic and debilitating condition that affects 10 -20% of New 
Zealanders. Furthermore, the prevalence of IBS is increasing and hence the number of 
patients requiring low FODMAP dietary management is increasing. Yet, there is not capacity 
within the public health system to deliver one-to-one low FODMAP education in a safe and 
effective manner. The findings of the present study, demonstrate group low FODMAP 
education to be a feasible and effective delivery pathway as opposed to the traditional one-to-
one pathway.   
 
In dietetic practice, patients with a medical diagnosis of IBS are usually referred to a 
specialised gastroenterology dietitian for one-to-one low FODMAP education. Low 
FODMAP education is a specialised area of dietetics and requires additional training to 
educate and counsel patients on low FODMAP dietary management. However, referring a 
patient to the public pathway for the low FODMAP diet would require a prolonged waiting 
time unless the patient was perceived as an urgent or severe case. The other alternative would 
be to refer patients to a private dietitian who specialises in low FODMAPs. Yet, the latter is 
more costly for patients and many tend to reject this option for this reason. Our findings 
suggest that a dietitian led group based low FODMAP education programme could mean that 
patients that otherwise wouldn’t be seen in the public system, would be able to access low 
FODMAP education. Overall, more IBS patients will be reached in a group delivery model 
compared to the traditional pathway. 
 
Yet, it is important to remember that all patients are unique and not all patients will be 
suitable for group education. Patients that lack motivation, have other dietary restrictions (in 
addition to FODMAPs) and other health issues should be screened beforehand to assess 
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suitability in one-to-one or low FODMAP education. In practice, there is limited time and 
resources to undergo a vigorous screening process. Instead a checklist of five questions could 
be utilised for further screening. Examples include: ‘Do you currently have any dietary 
restrictions?’, ‘Are you willing to make significant dietary changes for six weeks?’ 
Furthermore, dietitians should liaise with general practitioners and educate them the 
importance and utilisation of the screening process, in addition to the exclusion criteria. 
 
This research experience has been one that was completely different to the candidate in her 
past five years as a university student. In terms of the candidate’s individual dietetic practice, 
having the privilege to be involved in a pilot study with Canterbury Initiative (CI) has enable 
a greater understanding into the processes and intricacies involved when developing a 
nutrition programme. By working with the staff at CI and the CDHB, the candidate was able 
to develop a greater understanding of the challenges, organisation, processes and team work 
involved to run a pilot group education session. This insight has helped the candidate to 
identify possible challenges and have the necessary skills for problem solving in all sorts of 
situations and settings. The candidate has also learnt to develop tailored communication skills 
to different stakeholders involved in the programme, including CI staff, CDHB staff as well 
as with participants. The candidate intends to continue to reflect on this learning and apply it 
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PowerPoint slides – First education session 









































































PowerPoint slides- Second education session  
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Group Education on the Low FODMAP Diet 
Thank you for attending today’s session facilitated by Leigh O’Brien, dietitian.   
We would really appreciate your feedback about the session. This will help us to ensure future sessions are 
useful for people with Irritable Bowel Syndrome (IBS). 
Please read the statements below and circle the appropriate number. 
 
   Strongly    Strongly 
   agree    disagree
  
1. The content was pitched at the right level  1 2 3 4 5 
 
2. The session was well paced within the allotted time 1 2 3 4 5 
 
3. Session length was just right 1 2 4 4 5 
 
4. Leigh was a good communicator 1 2 3 4 5 
 
5. The material was presented in an organized manner 1 2 3 4 5 
 
6. I feel confident about following a low FODMAP diet 1 2 3 4 5 
 
7. I would recommend this group education to other 
people with IBS. 1 2 3 4 5 
 
8. Please rate the following: 
 Excellent Very Good Good Fair Poor 
a. Time of day      
b. Parking      
c. Meeting room      
d. Acoustics      
e. Slides      
f. Hand-outs      
g. The session overall     
     





10. How could the session be improved?  
               
 
 
 
